Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CENTENE CORPORATION

(CNC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Centene : 2021 outlook grows murky for insurers as COVID-19 surges

07/28/2021 | 12:37pm EDT

Surging COVID-19 cases are blurring the view for health insurers of how 2021 will play out.

Medicare Advantage coverage specialist Humana said Wednesday that it was maintaining its 2021 earnings forecast, citing “heightened uncertainty” about the ongoing pandemic.

That came a day after another insurer, Centene, also maintained its forecast for the year instead of raising it like rivals UnitedHealth Group and Anthem Inc. when they reported second-quarter results earlier this month.

The seven-day rolling average for daily new cases in the United States has jumped from about 24,000 shortly before UnitedHealth reported earnings on July 15 to more than 61,000 Tuesday, according to data from Johns Hopkins University.

COVID-19 cases had been falling for weeks, while insurers saw care use return to more normal levels as patients came back to surgery centers and doctor’s offices for care not related to the coronavirus. But a more contagious variant of the virus that causes COVID-19 has started to change that in the past week or so, spreading largely among people who have not received COVID-19 vaccines.

“It’s not business as usual as everybody had hoped,” Centene CEO Michael Neidorff told analysts on Tuesday, noting that the insurer has shown in the past that it can manage through “COVID-type issues.”

Centene Corp. covers or manages coverage for about 25 million people. Neidorff said about half of their customers are vaccinated.

Nationally, 60% of the adult U.S. population is fully vaccinated while 69% have had at least one dose, according to the Centers for Disease Control and Prevention.

Health insurers reaped huge profits early in the pandemic as patients cancelled or put off medical care and stayed home to avoid being exposed to the virus. That break in claims was countered a bit by increased costs for COVID-19 testing and treatment.

Humana executives told analysts Wednesday that they’ve started seeing an increase in COVID-19 cases in the last couple of weeks. It was too early to say whether that will be balanced again by a drop in care not related to the virus.

Humana CEO Bruce Broussard said 2021 is poised to be a “year of COVID-19 transition,” with next year returning more to normal.

Shares of several health insurers fell Wednesday in midday trading, led by a 6% drop from Humana Inc., which also reported better-than-expected second quarter earnings. Broader indexes were mixed.

Follow Tom Murphy on Twitter: @thpmurphy

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

All news about CENTENE CORPORATION
09/20CENTENE : Donates Connected Devices to Foster Youth
PR
09/15WALL STREET STOCK EXCHANGE : Yes, the global economic recovery is slowing
09/15ANALYST RECOMMENDATIONS : Chevron, Centene, Darktrace, Flutter, Malibu Boats...
09/14CENTENE : Mizuho Securities Adjusts Centene PT to $75 From $67, Maintains Neutral Rating
MT
09/14CENTENE : Morgan Stanley Adjusts Centene's Price Target to $79 from $88, Keeps Overweight ..
MT
09/14CENTENE : Credit Suisse Adjusts Price Target for Centene to $70 From $73.50, Maintains Neu..
MT
09/14REMINDER : Centene Corporation's 2021 Third Quarter Financial Results Conference Call
PR
09/08CENTENE : Bernstein Adjusts Centene's Price Target to $92 from $102, Keeps Outperform Rati..
MT
09/08CENTENE : Mizuho Securities Adjusts Centene PT to $67 From $75, Maintains Neutral Rating
MT
09/07RITE AID : Subsidiary Elixir Names Lance Neill Chief Operating Officer
MT
More news
Analyst Recommendations on CENTENE CORPORATION
More recommendations
Financials (USD)
Sales 2021 125 B - -
Net income 2021 1 191 M - -
Net Debt 2021 9 280 M - -
P/E ratio 2021 31,2x
Yield 2021 -
Capitalization 36 499 M 36 499 M -
EV / Sales 2021 0,37x
EV / Sales 2022 0,36x
Nbr of Employees 71 300
Free-Float 96,0%
Chart CENTENE CORPORATION
Duration : Period :
Centene Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CENTENE CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 62,60 $
Average target price 84,58 $
Spread / Average Target 35,1%
EPS Revisions
Managers and Directors
Michael F. Neidorff Chairman & Chief Executive Officer
Brent Davis Layton President & Chief Operating Officer
Andrew Lynn Asher Chief Financial Officer & Executive Vice President
Mary V. Mason Chief Medial Officer & Senior Vice President
Ken Yamaguchi Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
CENTENE CORPORATION4.28%36 499
UNITEDHEALTH GROUP16.55%385 370
ANTHEM, INC.16.94%91 550
CIGNA CORPORATION-2.97%68 698
HUMANA INC.-2.42%51 447
MOLINA HEALTHCARE, INC.32.94%16 190